Frontlight ResearchEarly access
Taking peopleNo phase
Prevention of Emergence Agitation in Rhinoplasty With Subanesthetic Propofol and Single-Dose Dexmedetomidine: A Prospective Double-Blind Clinical Study
Key facts
- Who runs it
- Yuzuncu Yil University
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 80 people, planned
- Started
- 15 Apr 2025
- Planned end
- 1 Feb 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Dexmedetomidine
- Propofol
- Record updated
- 27 August 2025
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patients scheduled for rhinoplasty
- Between 18-65 years
- ASA I-II group
Who cannot take part
- Those with renal,hepatic, cardiac and respiratory diseases
- Those with a known allergy to the medication to be used
- Those who are outside the age range of 18-65
- Those who are ASA III and above
- Those who underwent urinary catheterization
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To compare of prevention of emergence agitation in rhinoplasty with subanesthetic propofol and single dose dexmedetomidine
The 2 groups in the trial
- Dexmedetomidine (Group-D)Existing treatment, for comparison
Group-D: Dexmedetomidine group (n:40). In rhinoplasty, 10 minute infusion of 0,5 mcg/kg dexmedetomidine will be administered after nasal packing.
Treatment: Dexmedetomidine
- Propofol (Group-P)Treatment being tested
Group-P: Propofol group (n:40). In rhinoplasty, 0,5 mg/kg propofol IV bolus will be administered after nasal packing.
Treatment: Propofol
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Van Yuzuncu Yil University Faculty of Medicine Ethics Committee
- Fit questions
- Built from NCT07144007, who can take part
- Record updated
- 27 August 2025